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ABSTRACT: Quadriceps dysfunction, specifically weakness and central activation failure (CAF), has been implicated in the development
andprogressionofkneeosteoarthritis (OA), though fewdataareavailable to confirmitspresence inearlyOA.Thepurposeof this studywas to
determine the presence and magnitude of quadriceps dysfunction in those with and without early knee OA. Thirty-five female volunteers
were classified into two groups, OA (n¼ 22) and control (n¼ 13), based on the presence [Kellgren-Lawrence (K-L) grade 2] or absence (K-L
grade 0–1) of mild OA, respectively. Isometric quadriceps strength and central activation ratio (CAR) were assessed and compared between
groups utilizing a one-way ANOVA. Frequency statistics and Fisher’s exact test were used to compare the percentage of women with and
without CAF between groups. Quadriceps strength (control: 1.470.62Nm/kg; OA: 1.30 0.62Nm/kg; p¼0.45) was not significantly
different for women with and without mild OA. Further, the CAR (control: 0.910.07; OA: 0.87 0.12; p¼ 0.19) did not differ between
groups; however,women in both groups presentedwithCAF (control: 54%;OA: 73%;p¼ 0.29).Our results suggest that thewomenwithmild
osteoarthritis do not present with quadriceps dysfunction.  2009 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J
Orthop Res 28:595–599, 2010
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Tibiofemoral osteoarthritis (OA) is a common, debilitat-
ing disease. It is estimated that approximately 12% of
adults aged 60 and older in the United States have
symptomatic knee OA, while over 37% of individuals in
that age group present with radiographic evidence of
the disease.1 OA is a multifactorial pathology, with
a variety of possible contributing factors, including
genetic,2,3 metabolic,4 and biomechanical5,6 compo-
nents. Among these purported contributors to disease
initiation and progression is quadriceps dysfunction
[i.e., weakness and central activation failure (CAF)].
Quadriceps weakness is a common clinical sign of
knee OA7,8 that may contribute to its development and
progression. During weight bearing, the quadriceps
contract eccentrically to absorb energy.9 When the
quadriceps are weakened, their ability to absorb energy
is diminished and increased loads are borne by other
structures within the knee joint (e.g., the articular
cartilage), which may initiate the disease process or
enable its progression.10
One possible contributor to quadriceps weakness is
CAF. CAF decreases the ability to completely activate a
muscle by prohibiting recruitment of all motor units or
by failing to achieve maximal discharge rate from the
motor units that have been recruited.11 As the knee
joint provides sensory feedback to the central nervous
system, it is surmised that joint damage alters this
sensory information, leading to transmission of an
inhibitory signal to the quadriceps a-motoneuron pool,
ultimately decreasing voluntarymuscle activity.12 In the
case of knee OA, joint pain,13 effusion,14 and damage to
joint structures associated with the disease14,15 may
initiate quadriceps CAF. Previous research has demon-
strated the presence of CAF in individuals with sympto-
matic as well as moderate-to-severe radiographic knee
OA,9,16,17 suggesting that CAF contributes to quadriceps
weakness in the later stages of the disease process. CAF
has, in fact, been demonstrated to more strongly predict
quadriceps weakness than lean muscle cross-sectional
area in individuals with severe OA.18 If CAF does
contribute to the quadriceps weakness present in
individuals with knee OA, it seems that CAF could be
involved in the degenerative process, though few data
are available to support its role in the early stages of
the disease. Therefore, the purpose of this study was to
determine the presence and magnitude of quadriceps
dysfunction in women with and without mild tibiofe-
moral OA. We hypothesized that women with mild OA
would demonstrate greater quadriceps weakness and
CAF than women without OA.
METHODS
Participants
Volunteers were identified while participating in an ongoing
clinical trial to improve quadriceps strength in women with
knee OA. From the total of 46 available women, 35 were
enrolled in this study. Based on literature examining activa-
tion failure in persons with and without OA, we determined
that at least seven participants per group were necessary to
achieve 80% statistical power with an a-level of 0.05 and
an effect size of 1.46.19 Two groups, mild OA (n¼ 22) and
control (n¼ 13), were identified based on their medial
tibiofemoral compartment Kellgren-Lawrence (K-L)20 score
from bilateral radiographs. Women with K-L scores of 0–1
(absence or doubtful presence of radiographic OA) were
classified as not having knee OA and were assigned as
controls. Those women with K-L grade 2 (mild radiographic
features of OA) were classified as having early knee OA. The
limb with the higher K-L score was taken as the test limb. In
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participants with equal K-L scores bilaterally, the more
symptomatic limb was chosen as the test limb. Subjective
symptoms were assessed using theWestern Ontario McMaster
Universities Osteoarthritis Index (WOMAC),21 wherein par-
ticipants rated their symptoms on a scale from 1–5 (none to
extreme). Participants were excluded if they were morbidly
obese [body mass index (BMI)  40 kg/m2] or had moderate-to-
severe OA (K-L grades 3–4). Demographic information can
be found in Table 1. This study was approved by the University
of Michigan Health Sciences Institutional Review Board.
All participants provided written, informed consent prior to
participation.
Radiographic Assessment
Participants completed bilateral, weight-bearing, plain radio-
graph assessment in a semi-flexed position (Model X-GE
MPX-80; General Electric, Milwaukee, WI). Radiographs were
read for knee OA characteristics and classified according to the
K-L scale by one of the investigators (MFS) and a muscu-
loskeletal radiologist. If agreement on the K-L score was not
reached between the two readers, radiographs were re-read
and, if required, subjected to consensus reading by another
musculoskeletal radiologist. Inter-reader reliability was high
(kappa¼ 0.92). Precise details of the x-ray procedures and K-L
assessment methods are described elsewhere.22
Quadriceps Strength and Central Activation
Failure Assessment
Participants were seated on an isokinetic dynamometer
(Biodex System 3, Biodex Medical Systems, Shirley, NY) with
the hip flexed to 858 and the knee flexed to 908. Each woman
was secured to the dynamometer with the test leg being
fixed to the dynamometer arm and straps securing the thigh
and pelvis. Three repetitions of a knee extension maximal
voluntary isometric contraction (MVIC) were performed with
2-min rest provided between repetitions to limit the effects of
fatigue on the measurement. The torque signal was exported
from the dynamometer to a separate data acquisition unit
(MP100, BIOPAC Systems, Inc., Goleta, CA) for real-time data
acquisition. The peak MVIC value over the three repetitions
was normalized to participant body mass (kg) and used to
quantify quadriceps strength (Nm/kg).
During the performance of eachMVIC, quadriceps CAFwas
also assessed. Stimulating electrodes were placed over the
proximal rectus femoris and distal vastus medialis of the test
limb. Using the burst superimposition technique, a supra-
maximal electrical stimulus (100 pps train, 600 ms pulse
duration, train duration 100 ms, and maximum voltage of
130 V)9,23 was delivered (GRASS S88 and SIU8T, Astro-Med,
Inc., West Warwick, RI) to the participants while they
performed the previously described knee extension MVIC.
The central activation ratio (CAR) was calculated for each
repetition using the following equation:




where MVIC torque is the mean torque value 150 ms prior to
and including the delivery of the electrical stimulus, and
Superimposed burst torque is the maximum torque value
elicited via the electrical stimulus. A CAR of 1.0 represents
maximum voluntary activation. For this study, the previously
reported definition of CAR > 0.959 was used to represent full
activation and, therefore, the absence of CAF. The peak CAR
over the three repetitions was used to quantify quadriceps
central activation. For both quadriceps strength and CAF
assessment, practice trials were performed until participants
felt comfortablewith the tasks, and enthusiastic verbal support
was provided to the participants during testing, with each
participant continuously being encouraged to increase/max-
imize the magnitude of her MVIC.
Statistical Analysis
Separate 1 2 analyses of variance (ANOVA) were performed
to compare group means for each of the dependent variables
(quadriceps strength and CAR), as well as compare demo-
graphics information between the two groups. A frequency
table was generated to identify the number of women in each
group with none–mild and moderate–severe scores on the
WOMAC pain subscale, as well as the number of women with
and without CAF in each group. Fisher’s exact test was used to
determine if the frequencies for pain and CAF differed for each
group. The a-level was set a priori at p 0.05 for all tests.
RESULTS
Participant demographics were similar between groups
(Table 1). Peak quadriceps strength did not differ
between groups [control: 1.470.62 Nm/kg, median¼
1.34 Nm/kg, 95% confidence interval (CI)¼1.11–1.82;
mild OA: 1.30 0.62 Nm/kg, median¼ 1.22, 95%
CI¼1.03–1.57; p¼0.45] (Fig. 1). Further, no statisti-







Age (years) 57.31 2.50 58.41 2.99
Height (cm)* 166.46 4.67 161.22 5.63
Weight (kg) 89.21 13.76 84.89 16.85
BMI (kg/m2) 31.46 5.45 32.70 6.58
WOMAC total 36.46 15.26 42.50 18.06
WOMAC pain 7.85 3.58 8.82 3.74
WOMAC stiffness 3.69 1.97 4.00 1.66
WOMAC disability 26.69 10.87 29.68 12.54
BMI, body mass index; OA, osteoarthritis; WOMAC, Western
Ontario McMaster Universities Osteoarthritis Index.
aMeanSD.
*Statistically significant difference between groups (p<0.05).
Figure 1. Average (þSE) peak quadriceps strength (Nm/kg) for
each group.
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cally significant group mean differences were identified
for quadriceps CAR (control: 0.910.07, median¼ 0.93,
95% CI¼ 0.86–0.97; mild OA: 0.870.12, median¼
0.90, 95% CI¼ 0.82–0.91; p¼ 0.19) (Fig. 2). CAF was
present in 54% of control and 73% of OA participants
(p¼0.29) (Table 2). Knee pain was either absent or mild
in severity in 77% of control and 64% of OA participants
for the WOMAC pain subscale (p¼0.48) (Table 2).
DISCUSSION
Quadriceps dysfunction is often implicated in the
initiation and progression of knee OA24–27; yet evidence
of its presence early in the disease process is lacking.
Our study is the first to examine if quadriceps activation
failure is present in women with mild/early osteo-
arthritis. Establishing the presence of quadriceps
dysfunction, or lack thereof, in women with early
evidence of the disease may lend to a better under-
standing of whether it is indeed plausible that quad-
riceps dysfunction appears in the initial stages of the
disease process and could contribute to its onset and
progression. Our findings suggest that quadriceps
dysfunction is not different between healthy women
and those with early OA, calling into question the
previously presented hypothesis10 that quadriceps
dysfunction contributes to the pathogenesis of OA.
Contrary to our hypothesis, there was no statistically
significant difference in quadriceps strength between
the OA and control groups. This finding is in disagree-
ment with previous research demonstrating that indi-
viduals without knee OA have greater quadriceps
strength than those with OA.7,9,28 Though there is a
discrepancy between our results and those of others, the
magnitude of the normalized strength values29 is similar
to those reported previously for individuals with and
without OA using similar procedures to those of ours.
In disagreement with our hypothesis, our results
demonstrated that the magnitude of CAF was not
statistically different between women with and without
early OA. Previous research examining the relationship
between quadriceps CAF and knee OA is conflicting.
Several studies19,26,30 have found that individuals with
OA demonstrate significantly greater CAF than those
without OA, though these studies included individuals
with moderate and severe OA (K-L grades 3–4). Our
results doagree, however,with those ofLeweketal.9who
found no difference in the CAR between individuals
awaiting high tibial osteotomy and healthy controls.
While there is some disagreement between our results
and those reported previously with regards to CAF, it
is worth noting that the magnitudes of CAF previously
reported for both healthy and osteoarthritic individuals
vary greatly. In fact, higher9,31 and lower16 CAR values
compared to the present results have been reported for
individuals with OA. Further, the CAR values of our
control participants are both similar to,32 and lower
than,9 those reported previously in healthy individuals.
Differences in study sample size, participant age, OA
severity and symptoms at the time of testing, as well as
methodological differences in voluntary activation
assessment, not only potentially explain discrepancies
between our work and that of other researchers, but also
make comparing the results of this study with previous
work difficult.
One possible explanation for the lack of difference
between groups in both quadriceps strength and CAF is
the classification system employed. Participants in our
study were grouped according to the traditionally
accepted standards regarding the presence or absence
of OA, with K-L grades 0–1 representing the absence of
OA, though all of our control participants presentedwith
K-Lgrade1 radiographs.Evidence is available, however,
to suggest that a K-L grade of 1 may represent emergent
OA rather than the complete absence of OA. Hart and
Spector33 demonstrated that over 60% of individuals
with K-L grade 1 radiographs progressed to K-L grade 2
or higher over a 10-year follow-up period. Additionally,
our research group22 has reported that women with K-L
grade 1 radiographs at baseline were 2.2 times more
likely to developK-L grade 2 or higherOAwithin 3 years
compared with K-L grade 0. Considering these studies,
the absence of a statistically significant difference in
quadriceps strength and CAF may indicate that K-L
grades 1 and 2 actually represent a similar population,
those with early OA. If quadriceps weakness is a
contributor to the onset of the osteoarthritic disease
process, as has been suggested,24,27 then decrements in
Figure 2. Average (þSE) peak quadriceps central activation
ratio for each group.








None–mild (1–2) 10 (77%) 14 (64%)
Moderate–severe (3–5) 3 (23%) 8 (36%)
Central activation failure
No (CAR> 0.95) 6 (46%) 6 (27%)
Yes (CAR< 0.95) 7 (54%) 16 (73%)
CAR, central activation ratio; OA, osteoarthritis; WOMAC, West-
ern Ontario McMaster Universities Osteoarthritis Index.
aData are number of cases (percentage of group).
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quadriceps functioningwould likely arise prior to clinical
evidence ofOA.As such,we could speculate thatCAFand
quadriceps strength deficits would occur similarly in
both our groups if K-L grade 1 is indeed an indicator of
future OA. It is important to keep inmind, however, that
we could not ascertain the length of time the women in
our study presented with their current K-L score. The
amount of time in a disease stage may, in fact, affect the
presence or magnitude of quadriceps dysfunction, but
this is yet to be determined.
The lack of significant differences between groups in
our study may also be attributable to the majority of
individuals enrolled reporting mild symptoms, indicat-
ing no pain or mild pain on the WOMAC pain subscale.
Previous research16,34,35 has demonstrated that knee
pain and quadriceps strength and activation are likely
inversely related, with increased pain corresponding
to greater weakness and CAF. If pain is critical to
quadriceps dysfunction initiation, it seems that the
similar pain levels in our groups may be an indicator of
similar quadriceps strength and activation. Further,
though there was no mean difference between the two
groups, our participants did present with quadriceps
dysfunction, calling into question the belief that pain is a
necessary risk factor for muscle dysfunction. Instead, it
seems that other factors, such as joint damage, may be a
more important contributor than pain to quadriceps
dysfunction in the early stages of the disease process.
While there was a lack of significant difference for
quadriceps CAF between the OA and control groups, it
is important to note that approximately 66% of all
participants, regardless of disease state, demonstrated
quadriceps CAF. The activation failure present in our
study sample may reflect the age-related decline in
muscle activation that has been reported previously.36
Alternatively, if a K-L score of 1 is indeed representative
of emergentOAas discussed above, the high frequency of
activation failure in our sample may be attributable to
the OA disease process. Research examining the preva-
lence of activation failure inhealthyadults across theage
span and in osteoarthritic patients in various stages of
the disease is also needed to better understand the
genesis of OA-related CAF.
It should benoted that the frequency of participants in
our study presenting with CAF is dependent upon our
operational definition of CAF (a CAR<0.95). Although
this definition of CAF has been utilized previously in the
literature,9 it is important tokeep inmind that its clinical
meaningfulness is unknown. Whether a person with a
CAR of 0.95 or higher has less physical dysfunction than
a person with a lower CAR value requires future study.
Research also needs to be directed at identifying the
magnitude of CAF that results in clinical symptoms and/
or biomechanical adaptations.
Quadriceps strength, in addition to its importance in
lower extremity biomechanics,37,38 may be related to
functional performance and knee symptoms. Several
researchers have reported that increased quadriceps
strength leads to improvements in functional perform-
ance and self-reported knee function, as well as a
reduction in symptoms.39–42 As both of our groups
displayed quadriceps CAF, interventions designed to
counter the activation deficits inmiddle-aged adultsmay
lead to enhanced functional ability and reduced pain in
this population.
A potential limitation of this study is the small sample
size (control: n¼13; OA: n¼ 22) employed. While an a
priori power analysis revealed the need for aminimumof
seven participants per group, it is possible that including
additional participants could have yielded statistical
significance, suggesting greater quadriceps dysfunction
in individuals with mild radiographic OA. However,
considering the relatively small effect sizes (quadriceps
strength: Cohen’s d¼0.27; quadriceps CAF: Cohen’s
d¼0.41), we question whether statistically significant
differences in quadriceps dysfunction between groups
would be clinically meaningful.
While the burst superimposition technique is a
frequently utilized,9,16,18,31,36 sensitive43 measurement
of muscle activation, it is not without limitations. The
CAR derived from the burst superimposition testing
has been suggested to overestimate activation failure.44
Further, an assumption of this and other similar
techniques is that participants generate a true maximal
voluntary contraction, as failure to do sowould result in a
greatermagnitude of CAFand, accordingly, a lowerCAR
than is actually present. Despite efforts to maximize
participant effort through familiarization with the task
and robust verbal encouragement/feedback, it is diffi-
cult, if not impossible, to ensure our participants put
forth a truly maximal effort.
In conclusion, quadriceps strength and CAF were not
different among women with early osteoarthritis (K-L 2)
and controls (K-L 0–1). Despite a lack of difference
between groups, 66% of participants in our sample
demonstrated quadriceps CAF. The presence of activa-
tion failure in this sample suggests that quadriceps
strengthening interventions may be prudent in middle-
aged women. Though our results imply that the
magnitude of quadriceps dysfunction does not differ
between women with early OA and controls, future
studies should consider that a K-L score of 1 may
represent emergent OA. Further research, ideally in
the form of longitudinal studies, is needed to better
elucidate the role of quadriceps dysfunction throughout
the knee OA process.
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